Delivery Order SPE2DR25D1202-SPE2DR26F75AB
Award Date 2/18/26
Potential Completion Date 2/19/26
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,373.26 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (60 ml). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Performance will be conducted at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. AmerisourceBergen Drug Corp, a...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, with a ceiling value of $2,267.66 for supply of Quillivant XR 25 mg/5 ml suspension (60 ml).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 11, 2026. The order is priced on a firm fixed-price basis and carries no set-aside.</p>
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $1,049.72 for supply of Quillivant XR 25 mg/5 ml suspension, 120 ml. Place of performance is Conshohocken, PA. Ultimate completion date is February 10, 2026. The order is firm fixed price with no set-aside.</p>
- On January 30, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $5,325.85 to AmerisourceBergen Drug Corp for the supply of Quillivant XR Oral Suspension 150ML 5MG/ML. The contract, which is not set-aside, has an ultimate completion date of February 2, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120ml quantities, valued at $1,526.88. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 1, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml), valued at $1,234.22. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of December 31, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,473.16 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 12, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a contract ceiling value of $2,401.91. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, executed without a set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity, valued at $1,807.02. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by June 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,104.92 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180 ml) on January 16, 2026, with an ultimate completion date of January 20, 2026. This non-set-aside, firm fixed-price contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...